Redeye gives a short comment on today’s news that IRLAB extends its runway following “extended and e...
Redeye notes that the underlying Q4 figures came in stronger than anticipated, primarily due to bett...
Vaisala's Q4 results aligned with the preliminary figures the company disclosed in January.
Strong organic growth in Q4 at 18%, albeit 2% below ABGSCe Q4 adj.
Gentoo Media reported solid topline in Q4 while EBITDA was somewhat softer than expected, partly due...
CoinShares reported its best quarter ever on AUM Beat on Capital Markets, miss on Asset Management U...
Net sales SEK 202m, +7% vs ABGSCe and Factset cons.
Redeye provides an update following Nitro Games’ Q4 2024 report, which came in slightly better than ...
Redeye provides an update following Corline’s Q4 2024 report.
We lower our 2025-26 sales estimates by 4%, mainly driven by Germany.
Redeye endorses today’s news that AlzeCure has received a EUR2.
Minor positive revisions following solid Q4 Growing CEPS 40% in 2025e '25e P/CEPS ~13x (25% below se...
Redeye strengthens its positive view of Formpipe following the Q4 report.
Aspo’s Q4 earnings came in a bit soft relative to estimates, but the midpoint of FY’25 comparable EB...
Redeye expects strong performance from the Lifecare division in Q4 2024, though weaker results from ...
